The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors
2022 · Antioxidants · 55 citations
https://doi.org/10.3390/antiox11020235
J
Jorge Gutiérrez‐Cuevas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
638
Citations
8
h-index
8
i10-index
Jorge Gutiérrez‐Cuevas is an academic researcher from Universidad de Guadalajara. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Genomics, phytochemicals, and oxidative stress & Peroxisome Proliferator-Activated Receptors. The author has an h-index of 8, co-authored 16 publications.
ORCID: 0000-0003-0276-0428Papers by this author
worksPirfenidone decreases insulin, glucagon, leptin, plasminogen activator inhibitor 1, preventing nonalcoholic steatohepatitis and myocarditis in an obesity moldel
2024 · Annals of Hepatology · 0 citations
https://doi.org/10.1016/j.aohep.2024.101407
Pirfenidone Prevents Myocarditis by Restoring Metabolic Hormone Levels in a Mouse MASH Model and its Effect on H9c2 Myoblast Viability under Glucolipotoxicity
2025 · Annals of Hepatology · 0 citations
https://doi.org/10.1016/j.aohep.2025.101843
Nopal and Pirfenidone Ameliorate Epididymal Fat Weight and Anthropometric Parameters in a Mouse Obesity Model with Diethylnitrosamine
2025 · Annals of Hepatology · 0 citations
https://doi.org/10.1016/j.aohep.2025.101859
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat